Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-11 to 2024-01-03
Current total value of award: $669.26
Description: 4563107210!ZOLADEX 3.6 MG IMPLANT SYRNS